Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. - Wikidata - wikimedia - TriplyDB

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

http://www.wikidata.org/entity/Q33927756

about

Neuralgias of the Head: Occipital Neuralgia Evidence-Based Treatments for Adults with Migraine Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection Development of onabotulinumtoxinA for chronic migraine Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.Procedures for administering botulinum toxin type A for migraine and tension-type headache.Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study.Botulinum toxin type B: a new injectable treatment for cervical dystonia.Review of botulinum toxin type A and its clinical applications in migraine headache.Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.Treatment of headache with botulinum toxin A--a review according to evidence-based medicine criteria.Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.OnabotulinumtoxinA for chronic migraine: a critical appraisal.Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.Treatment of headache with botulinum toxin administration.The efficacy of intradermal injection of botulinum toxin in patients with post-herpetic neuralgia Resolution of chronic migraine headaches with intrathecal ziconotide: a case report.General principles of migraine management: the changing role of prevention.Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.Botulinum toxin: could it be an effective treatment for chronic tension-type headache?Treatment of headaches with botulinum toxin.A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment Botulinum toxin type A in chronic migraine.Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.Neuro-ophthalmologic manifestations of primary headache disorders.OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine.Botulinum toxin in the management of chronic migraine: clinical evidence and experience.Botulinum toxin and the treatment of headache: a clinical review.Muscle trigger point therapy in tension-type headache.Emerging treatment for chronic migraine and refractory chronic migraine.A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.OnabotulinumtoxinA for the treatment of headache.Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society.Is Migraine Surgery Ready for Prime Time? The Surgical Team's View.Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series.

P2860

Q26751315-F47104C0-170B-4D69-8440-D73C49A814D9 Q26769968-3B3B5277-136F-4EAF-B7C6-A158EE5141D1 Q26781281-D6B7465F-7527-458E-AB53-8C0D969459B9 Q26799317-A7E0097C-DBEB-45E7-A181-2D8746163D32 Q27027006-B213BB1F-1D8D-49FE-A699-79A65F485394 Q33475067-9EBCCBEA-EE0E-4D12-9273-FE390D26B1B2 Q33967971-5974BC86-41EA-40C2-A2C4-1596ECB619BB Q33974749-40A3F007-B216-4266-A873-7AC4F5078623 Q34481941-9BBB4BDD-4189-45A1-980D-6FA1936BBEFB Q34515421-E2D10660-79C8-4537-A58D-5946680CAE28 Q34593652-F4E02CF4-2A3D-497E-887D-7E35C8DDAA1F Q34991596-CCBD7DD3-EEEB-4FA1-A50F-0A4D145D9EE9 Q35187508-838D5A15-32F9-4C64-B058-FE3AD9CA0365 Q35206639-62CCD674-9A16-4477-BBD4-DEF8983755AB Q35681903-FD6EE38A-AA83-4C94-863C-E1D34888A700 Q35697217-804517D1-10E2-4872-9395-8CF2FDF90460 Q35822040-890C8A72-D0F6-446F-A56D-DD6221337CDF Q35872011-A5F69D22-FDF1-47A0-BF39-92674B360E23 Q35932284-52717766-941E-40BD-A549-BF90BB0D4D01 Q36022459-DB954118-3E2E-4259-80AF-7C6D0B8BB627 Q36068584-AC8BD8B9-683C-4FC4-B248-F63FF0ED942D Q36099512-4DFB5E29-D073-4790-B311-D403E49B1661 Q36107237-159B4D28-6E26-411F-A312-12F6CBA48DFF Q36259831-7CCACAD1-94D0-4484-BD78-D17E7C20FB0B Q36419558-F674EAED-264F-4E20-A431-8821793866D0 Q36510912-A629B434-1968-4042-A729-41EC074AE378 Q36817036-392AFD6F-BDA8-4742-BF31-52A43ECDE3DD Q37128357-E4E54829-15E6-440A-9DBF-CC3959BF5E1A Q37146193-71D569F6-64FF-4CF2-899F-966B88252512 Q37678415-AE96FD02-017D-4C02-956F-1FBEA66AD7EC Q37722781-2AB834D2-2362-4E8F-AF77-79990CCED902 Q37955981-41484D4A-5DDF-42F8-8E4C-D7AB81460CFC Q37987990-9EDC1389-9C07-4034-A0E7-EE106AE48C1B Q38031982-A095970B-D23A-40A1-92BE-2D3F4DF644ED Q38118652-65216040-AC67-4F26-B90E-DDC279AF3550 Q38136258-532A6C10-B549-4309-82D3-AF85479AD52A Q38223491-8B0553E7-DC75-41DB-9ED4-C01E00AA4E5B Q38609191-A697587E-7AE8-4F15-955C-B1A5721F0DA0 Q39133314-FBC919C9-CB5D-4E4A-9E88-BAC8306BF9CA Q39327986-1DD8D9D5-1781-40D9-9296-49DB6CDE6E40

P2860

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

http://www.wikidata.org/entity/Q33927756

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@ast

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@en

type

label

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@ast

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@en

prefLabel

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@ast

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@en

P1433

Q33927756-11821765-52D1-472C-8752-3574BB5EE59C

P1476

Q33927756-8FC4AC7E-0E07-4119-9E0C-392790345279

P2093

Q33927756-0914B1DC-0053-45FD-9FEB-6D4A2424FAC3

Q33927756-30663F26-D9D5-42A5-B22E-E35D64F893B0

Q33927756-31E64D9C-D52E-4BA1-8FF7-30A3AA4745C5

Q33927756-94F5EC22-D6D0-42F4-92CF-601953425B5E

Q33927756-CFA5D46B-72E2-4005-AA5E-D455A6ABC684

P2860

Q33927756-1FDD2A16-9973-4FE6-B6EA-4EC688C10AAE

Q33927756-2093944C-1236-4B37-8339-DF34575B19AA

Q33927756-44F11F72-C2E4-4D16-9AE9-5E24CF189FAB

Q33927756-6B5936C3-1B84-45DC-A011-8C5404720C7E

Q33927756-75745D8B-EA60-4EBC-B134-7E4F43E60C47

Q33927756-76BBA68C-B8EF-4CA9-9DC4-B1586B562C00

Q33927756-99382BB1-28A8-4BFF-A900-8B2DE40450D7

Q33927756-AF08EB83-7595-4FC4-95A6-14CA1AB219A0

Q33927756-B384C9E1-967E-4BC6-BCCB-0FA15D90A4C1

Q33927756-D1E2D338-ABB6-4CE6-B1D9-3D4F560C6E8A

P304

Q33927756-FE8CF3CE-FB6B-4F72-BC3B-C85DC5DF351F

P31

Q33927756-FBF67C8F-19EB-461D-AF06-67119BC18666

P356

Q33927756-CF2C45F4-AF6B-45B5-9A04-1FFA82F81569

P433

Q33927756-9AE478A8-F2D2-4973-A3A3-FDA8B491C718

P478

Q33927756-9A7CB002-54E6-47B7-9262-741482569C6F

P577

Q33927756-D78A86C4-6F1F-4F0A-8D90-93E6CDB85418

P5875

Q33927756-4ACB9610-25D1-404B-B4E3-40D4A10CD09A

P698

Q33927756-378383EC-0DE0-44BC-B195-983CF62B920E

P921

Q33927756-94FAEA32-1289-43F0-A49D-D1F8AF3B80CE

Q33927756-D1B51B67-A9FD-4724-AF06-38AB6390EFD0

P356

MHN.2000.110960

P1433

Otolaryngology-Head and Neck Surgery

P1476

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

@en

P2093

A Blitzer

http://www.w3.org/2001/XMLSchema#string

J M Pogoda

http://www.w3.org/2001/XMLSchema#string

L D Schoenrock

http://www.w3.org/2001/XMLSchema#string

M F Brin

http://www.w3.org/2001/XMLSchema#string

W J Binder

http://www.w3.org/2001/XMLSchema#string

P2860

Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems.

Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs.

Correlation between essential tremor and migraine headache

Status epilepticus and antiepileptic medication levels.

The synaptic vesicle and its targets.

High-frequency stimulation of the facial nerve results in local cortical release of vasoactive intestinal polypeptide in the anesthetised cat.

Neuropeptide Y co-exists with vasoactive intestinal polypeptide and acetylcholine in parasympathetic cerebrovascular nerves originating in the sphenopalatine, otic, and internal carotid ganglia of the rat.

The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.

Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP).

The neurobiology of vascular head pain.

P304

669-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MHN.2000.110960

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12215109

http://www.w3.org/2001/XMLSchema#string

P698

11112955

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder